Drugs / Tacrolimus (TAC)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01713400 Background | Feb 2013 → Oct 2014 | graft versus host disease | H. Lee Moffitt Cancer Center and Research Institute | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tacrolimus (TAC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01713400 ↗ |